ONG-TERM FOLLOW-UP OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALFA: RELATION TO POLYMORPHISMS IN IL28B AND APOLIPOPROTEIN E LOCI (INTERFERLONG STUDY)
- Conditions
- chronic hepatitis Bliver inflammation1001965410047438
- Registration Number
- NL-OMON39063
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 135
Inclusion Criteria
chronic hepatitis B
treated with interferon
Exclusion Criteria
coinfections with HIV, HCV
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>IL28b & Apo E genotype --> HBeAg and HBsAg loss.</p><br>
- Secondary Outcome Measures
Name Time Method <p>-</p><br>